Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance Trial

Medcalf, E., Ackermann, D. M., Williams, J. T. W., Turner, R. M., Espinoza, D., Wu, Z., Fann, A., Kharel, P., Janda, M., Cust, A. E., Irwig, L., Hersch, J. K., Low, D., Low, C., Guitera, P., Martin, L. K., Soyer, H. P., Azzi, A., Lilleyman, A., Rosengren, H., … Bell, K. J. L.

Krista Verlis 17/10/24 Krista Verlis 17/10/24

Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses

Ackermann D, Hersch J, Jordan D, Clinton-Gray E, Bracken K, Janda M, Turner R, Bell K.

Krista Verlis 26/3/24 Krista Verlis 26/3/24

Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma

Deonna M. Ackermann, Jolyn K. Hersch, Monika Janda, Karen Bracken, Robin M. Turner, Katy J.L. Bell

Guest User 21/1/24 Guest User 21/1/24

Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance

Jake T. W. Williams, Katy J. L. Bell, Rachael L. Morton & Mbathio Dieng.